Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Johnson

Showing results (211-220 of 229) with videos related to

Pageof 23
Sort By:
Cancer Research|August 5, 2000
Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cellsS L Kominsky, A C Hobeika, F A Lake, et al.
Journal of Neuroimmunology|May 1, 1997
Oral feeding of interferon tau can prevent the acute and chronic relapsing forms of experimental allergic encephalomyelitisJ M Soos, M G Mujtaba, P S Subramaniam, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 5, 1999
Expression, purification, and characterization of interferon-tau produced in Pichia pastoris grown in a minimal mediumT M Johnson, S K Holaday, Y Sun, et al.
Biochemical and Biophysical Research Communications|December 28, 1983
Antibodies to a synthetic peptide corresponding to the N-terminal end of mouse gamma interferon (IFN gamma)M P Langford, P W Gray, G J Stanton, et al.
Oncogene|January 9, 1999
IFNgamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1/CIP1S Kominsky, H M Johnson, G Bryan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988
Use of synthetic peptides to identify an N-terminal epitope on mouse gamma interferon that may be involved in functionH I Magazine, J M Carter, J K Russell, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 1, 1996
Structural requirements for agonist activity of a murine interferon-gamma peptideB E Szente, I J Weiner, M J Jablonsky, et al.
Biochemistry|June 1, 1993
Proton NMR sequence-specific assignments and secondary structure of a receptor binding domain of mouse gamma-interferonT T Sakai, M J Jablonsky, P A DeMuth, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1993
Binding site on the murine IFN-gamma receptor for IFN-gamma has been identified using the synthetic peptide approachM A VanVolkenburg, N D Griggs, M A Jarpe, et al.
Annals of the New York Academy of Sciences|January 1, 1980
Immune interferon: some properties and functionsS Baron, J E Blalock, F Dianzani, et al.
Pageof 23

Showing results (211-220 of 229) with videos related to

Sort By:
Pageof 23
Cancer Research|August 5, 2000
Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cellsS L Kominsky, A C Hobeika, F A Lake, et al.
Journal of Neuroimmunology|May 1, 1997
Oral feeding of interferon tau can prevent the acute and chronic relapsing forms of experimental allergic encephalomyelitisJ M Soos, M G Mujtaba, P S Subramaniam, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 5, 1999
Expression, purification, and characterization of interferon-tau produced in Pichia pastoris grown in a minimal mediumT M Johnson, S K Holaday, Y Sun, et al.
Biochemical and Biophysical Research Communications|December 28, 1983
Antibodies to a synthetic peptide corresponding to the N-terminal end of mouse gamma interferon (IFN gamma)M P Langford, P W Gray, G J Stanton, et al.
Oncogene|January 9, 1999
IFNgamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1/CIP1S Kominsky, H M Johnson, G Bryan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988
Use of synthetic peptides to identify an N-terminal epitope on mouse gamma interferon that may be involved in functionH I Magazine, J M Carter, J K Russell, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 1, 1996
Structural requirements for agonist activity of a murine interferon-gamma peptideB E Szente, I J Weiner, M J Jablonsky, et al.
Biochemistry|June 1, 1993
Proton NMR sequence-specific assignments and secondary structure of a receptor binding domain of mouse gamma-interferonT T Sakai, M J Jablonsky, P A DeMuth, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1993
Binding site on the murine IFN-gamma receptor for IFN-gamma has been identified using the synthetic peptide approachM A VanVolkenburg, N D Griggs, M A Jarpe, et al.
Annals of the New York Academy of Sciences|January 1, 1980
Immune interferon: some properties and functionsS Baron, J E Blalock, F Dianzani, et al.
Pageof 23